OS
LLY icon

Objectivity Squared’s Eli Lilly LLY Stock Holding History

Objectivity Squared’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Hold
219
– – 0.15% 46
2026
Q1 		$201K Sell
219
-30
-12% -$30.4K 0.13% 53
2025
Q4 		$268K Buy
+249
New +$238K 0.15% 49
2025
Q3 		– Sell
-276
Closed -$215K – 55
2025
Q2 		$215K Hold
276
– – 0.15% 47
2025
Q1 		$202K Hold
276
– – 0.17% 43
2024
Q4 		$221K Hold
276
– – 0.15% 44
2024
Q3 		$248K Hold
276
– – 0.17% 42
2024
Q2 		$260K Hold
276
– – 0.2% 41
2024
Q1 		$210K Buy
+276
New +$196K 0.18% 42

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Objectivity Squared's LLY Position: Q2 2026 in Review

Objectivity Squared held its Eli Lilly (LLY) position steady in Q2 2026 at 219 shares worth $263K. The position accounts for 0.15% of the portfolio, ranked #46.

Objectivity Squared first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $268K in Q4 2025. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Objectivity Squared held 219 shares of Eli Lilly worth $263K as of Q2 2026.
  • Objectivity Squared left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.15% of Objectivity Squared's portfolio in Q2 2026, its #46 holding.
  • Objectivity Squared first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Objectivity Squared's Eli Lilly position peaked at $268K in Q4 2025.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Objectivity Squared's 13F filing for Q2 2026, filed 7 Aug 2026.